Have we successfully implemented CYP2D6 genotyping in psychiatry?

被引：4
作者：
de Leon, Jose [1 ,2 ,3 ]
机构：
[1] Univ Kentucky, Eastern State Hosp, Mental Hlth Res Ctr, Lexington, KY USA
[2] Univ Granada, Inst Neurosci, Psychiat & Neurosci Res Grp CTS549, Granada, Spain
[3] Univ Basque Country, Santiago Apostol Hosp, Biomed Res Ctr Mental Hlth Net CIBERSAM, Vitoria, Spain
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2017年 / 13卷 / 12期
关键词：
Biological markers; cytochrome P-450 enzyme system/genetics; drug monitoring; genotype; mental disorders/drug therapy/genetics; pharmacogenetics; psychotropic drugs/therapeutic use; United States Food and Drug Administration; AMPLICHIP CYP450 TEST; PHARMACOGENOMICS; MEDICINE;
D O I：
10.1080/17425255.2017.1406920
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1201 / 1203
页数：3
相关论文
共 15 条
[1]   Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting [J].
Bousman, Chad A. ;
Jaksa, Philip ;
Pantelis, Christos .
PHARMACOGENETICS AND GENOMICS, 2017, 27 (11) :387-393
[2]   Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness [J].
Chou, WH ;
Yan, FX ;
de Leon, J ;
Barnhill, J ;
Rogers, T ;
Cronin, M ;
Pho, M ;
Xiao, V ;
Ryder, TB ;
Liu, WW ;
Teiling, C ;
Wedlund, PJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (02) :246-251
[3]   Pharmacogenomics in Psychiatry: From Therapeutic Drug Monitoring to Genomic Medicine [J].
Crettol, S. ;
de Leon, J. ;
Hiemke, C. ;
Eap, C. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (03) :254-257
[4]   Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital [J].
de Leon, J ;
Barnhill, J ;
Rogers, T ;
Boyle, J ;
Chou, WH ;
Wedlund, PJ .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (09) :1278-1280
[5]   AmpliChip CYP450 Test: personalized medicine has arrived in psychiatry [J].
de Leon, Jose .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2006, 6 (03) :277-286
[6]   Pharmacogenetic Tests in Psychiatry From Fear to Failure to Hype [J].
de Leon, Jose .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (04) :299-304
[7]   Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses? [J].
de Leon, Jose .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (07) :532-534
[8]   DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping [J].
de Leon, Jose ;
Susce, Margaret T. ;
Johnson, Maria ;
Hardin, Mike ;
Maw, Lorraine ;
Shao, Alison ;
Allen, Antonette C. P. ;
Chiafari, Francis A. ;
Hillman, Grantland ;
Nikoloff, D. Michele .
CNS SPECTRUMS, 2009, 14 (01) :19-34
[9]   Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities [J].
de Leon, Jose ;
Arranz, Maria J. ;
Ruano, Gualberto .
CLINICS IN LABORATORY MEDICINE, 2008, 28 (04) :599-617
[10]   Prediction of CYP2D6 phenotype from genotype across world populations [J].
Gaedigk, Andrea ;
Sangkuhl, Katrin ;
Whirl-Carrillo, Michelle ;
Klein, Teri ;
Leeder, J. Steven .
GENETICS IN MEDICINE, 2017, 19 (01) :69-76
12